Brief: Genprex Gets EU Nod To Grant Patent For REQORSA And PD-1 Antibody Combo To Treat Cancer

Genprex

04/11/2025 12:40

Nov 4 (Reuters) - Genprex Inc GNPX.O:

GENPREX ANNOUNCES EUROPEAN PATENT OFFICE'S INTENT TO GRANT A PATENT FOR THE COMBINATION OF REQORSA® GENE THERAPY AND PD-1 ANTIBODIES TO TREAT CANCER

Source text: ID:nPn87ClQDa

Further company coverage: GNPX.O

 ((Reuters.Briefs@thomsonreuters.com;))